Logged out
Access All our Essays in an Instant
Swap your work for FREE access, or pay £4.99 for instant access
What moves should Monsanto now make? How will it meet the challenge from Du Pont?
Member rating: No Rating | Words: | Submitted: Mon Nov 10 2003
Page Preview
On the left is an image preview of every page of this document, and below are the first 150 words with formatting removed:
MEMORANDUM To: Hugh Grant, CEO From: Gregg Steiger , Jeff Feng Subject: What moves should Monsanto now make? How will it meet the challenge from Du Pont? Monsanto's greatest challenge is seemingly its greatest opportunity. As biotech companies produce "smarter" products, much of the world continues to resist the benefits. Despite the huge potential of genetically modified (GM) foods, Monsanto continues to be plagued by heavy spending, leadership changes and the high cost of marketing genetically altered crops to the world. Of Monsanto's two main products - genetically altered seeds and chemicals - Roundup has been Monsanto's cash cow for years and the mainstay of the company since 1901; however, the chemical business is in sharp decline. In 2003, biotech revenues are expected to surpass chemical revenues. In the face of this inflection point, Monsanto needs to take the position of an analyzer1, by protecting its biotech position, while also searching for new product and...
Get instant access
- Instant, unlimited access to our documents in full
- Swap your work for free access, or pay £4.99
- To see the full version of this document and 149,958 others
